The DEDUCE Model, A Cost-Utility Tool Using Patient-Level Microsimulation to Evaluate Sensor-Based Glucose Monitoring Systems in Type 1 and Type 2 Diabetes: Comparative Validation
To assess the accuracy and validity of the DEtermination of Diabetes Utilities, Costs, and Effects (DEDUCE) model, a Microsoft Excel-based tool for evaluating diabetes interventions for type 1 and type 2 diabetes. (Source: Value in Health)
Source: Value in Health - January 31, 2024 Category: International Medicine & Public Health Authors: Kirk Szafranski, Gerard De Pouvourville, Dan Greenberg, Stewart Harris, Johan Jendle, Jonathan E. Shaw, JeanPierre Coaquira Castro, Yeesha Poon, Fleur Levrat-Guillen Tags: Preference-Based Assessments Source Type: research
Estimating a Minimal Important Difference for the EQ-5D-5L Utility Index in Dialysis Patients
This study aims to estimate the MID for the EQ-5D-5L utility index in dialysis patients. (Source: Value in Health)
Source: Value in Health - January 31, 2024 Category: International Medicine & Public Health Authors: Amanda N. Siriwardana, Anna T. Hoffman, Rachael L. Morton, Brendan Smyth, Mark A. Brown Source Type: research
Discrete Event Simulation to Incorporate Infusion Wait-Time when Assessing Cost-effectiveness of a Chimeric-antigen Receptor T-cell Therapy
The main objective was to use discrete event simulation (DES) to model the impact of wait-time, defined as the time between leukapheresis and chimeric antigen receptor (CAR-T) infusion, when assessing the cost-effectiveness of tisagenlecleucel in young patients with relapsed/refractory acute lymphoblastic leukaemia. (Source: Value in Health)
Source: Value in Health - January 29, 2024 Category: International Medicine & Public Health Authors: Amy Gye, Richard De Abreu Lourenco, Stephen Goodall Source Type: research
The Cost of Atrial Fibrillation: A Systematic Review
Atrial fibrillation (AF) is the most common cardiac arrhythmia, with an increasing incidence and prevalence due to progressively ageing populations. Costs related to AF are both direct and indirect. This systematic review aims to identify the main cost drivers of the illness, assess the potential economic impact resulting from changes in care strategies and propose interventions where they are most needed. (Source: Value in Health)
Source: Value in Health - January 29, 2024 Category: International Medicine & Public Health Authors: Alessandra Buja, Vincenzo Rebba, Laura Montecchio, Giulia Renzo, Vincenzo Baldo, Silvia Cocchio, Nicola Ferri, Federico Migliore, Alessandro Zorzi, Brendan Collins, Che ïma Amrouch, Delphine De Smedt, Christodoulos Kypridemos, Mirko Petrovic, Martin O’ Tags: Systematic Literature Review Source Type: research
A Comparison of Items and Constructs of Standardized Health-Related Quality of Life and Mental Well-Being Measures
This study aimed to explore the internal constructs of the concepts being measured by EQ-5D-5L (a health-related quality of life measure that can produce preference-based utility values) and the 12-item General Health Questionnaire (GHQ-12, a mental well-being measure) and to understand to what extent the items of EQ-5D-5L and GHQ-12 associate with each other. (Source: Value in Health)
Source: Value in Health - January 28, 2024 Category: International Medicine & Public Health Authors: Zhuxin Mao, Jonas Cr èvecoeur, Koen Pepermans, Paul Kind, Thomas Neyens, Philippe Beutels Tags: Patient-Reported Outcomes Source Type: research
A Comparison of Items and Constructs of Standardized Health-Related Quality of Life and Mental Wellbeing measures
This study aimed to explore the internal constructs of the concepts being measured by EQ-5D-5L (a health-related quality of life measure that can produce preference-based utility values) and the 12-item General Health Questionnaire (GHQ-12, a mental wellbeing measure) and to understand to what extent the items of EQ-5D-5L and GHQ-12 associate with each other. (Source: Value in Health)
Source: Value in Health - January 28, 2024 Category: International Medicine & Public Health Authors: Zhuxin Mao, Jonas Cr èvecoeur, Koen Pepermans, Paul Kind, Thomas Neyens, Philippe Beutels Tags: Patient-Reported Outcomes Source Type: research
A comparison of items and constructs of standardised health-related quality of life and mental well-being measures
To explore the internal constructs of the concepts being measured by EQ-5D-5L (a health-related quality of life measure that can produce preference-based utility values) and the 12-item General Health Questionnaire (GHQ-12, a mental well-being measure), and to understand to what extent the items of EQ-5D-5L and GHQ-12 associate with each other. (Source: Value in Health)
Source: Value in Health - January 28, 2024 Category: International Medicine & Public Health Authors: Zhuxin Mao, Jonas Cr èvecoeur, Koen Pepermans, Paul Kind, Thomas Neyens, Philippe Beutels Source Type: research
Exploring the Comparability Between EQ-5D and the EQ Health and Wellbeing in the General Australian Population
This study aimed to explore the extent to which the EQ-HWB and EQ-5D-5L capture overlapping or complementary constructs and to explore the discriminative ability of the EQ-HWB Short version (EQ-HWB-S) as a multiattribute utility instrument in the Australian setting. (Source: Value in Health)
Source: Value in Health - January 26, 2024 Category: International Medicine & Public Health Authors: Peter Lee, Lidia Engel, Erica Lubetkin, Lan Gao Tags: Preference-Based Assessments Source Type: research
Drug Pricing, Patient Welfare, and Cost-Effectiveness Analysis
Cost-effectiveness analysis (CEA) is becoming more important in shaping healthcare benefit packages worldwide. The area in which CEA is applied most is in the context of new and often expensive medicines. The incremental cost-effectiveness of a new medicine is usually compared with a single threshold to determine whether it is eligible for reimbursement. Given that new medicines are often prescribed for multiple indications, the cost-effectiveness of a medicine can vary widely between indications for many reasons. (Source: Value in Health)
Source: Value in Health - January 26, 2024 Category: International Medicine & Public Health Authors: Pieter van Baal, Pedro Pita Barros Tags: Editorial Source Type: research
Exploring the comparability between EQ-5D and the EQ-HWB in the general Australian population.
This study aims to explore the extent to which the EQ-HWB and EQ-5D-5L capture overlapping or complementary constructs, as well as to explore the discriminative ability of the short-form EQ-HWB (EQ-HWB-S) as a multi-attribute utility instrument (MAUI) in the Australian setting. (Source: Value in Health)
Source: Value in Health - January 26, 2024 Category: International Medicine & Public Health Authors: Peter Lee, Lidia Engel, Erica Lubetkin, Lan Gao Tags: Preference-Based Assessments Source Type: research
Drug pricing, patient welfare and cost effectiveness analysis
(Source: Value in Health)
Source: Value in Health - January 26, 2024 Category: International Medicine & Public Health Authors: Pieter van Baal, Pedro Pita Barros Tags: Editorial Source Type: research
Table of Contents
(Source: Value in Health)
Source: Value in Health - January 20, 2024 Category: International Medicine & Public Health Source Type: research
Editorial Board
(Source: Value in Health)
Source: Value in Health - January 20, 2024 Category: International Medicine & Public Health Source Type: research
Validation of China Health-Related Outcomes Measures-Cardiovascular Disease
This study aimed to test the psychometric properties of CHROME-CVD. (Source: Value in Health)
Source: Value in Health - January 18, 2024 Category: International Medicine & Public Health Authors: Xue Li, Rui Li, Feiyi Xiao, Kun Zhao, Xiaolu Zhang, Xinyi Wang, Meichen Li, Ke Guo, Li Wang, Yanan Wu, Harriette Van Spall, Tiantian Gao, Qiang Fu, Feng Xie, CHROME Study Group Tags: Patient-Reported Outcomes Source Type: research
Partial Orphan Cancer Drugs: US Food and Drug Administration Approval, Clinical Benefit, Trials, Epidemiology, Price, Beneficiaries, and Spending
This study analyzes partial orphan cancer drugs’ development, approval, and economics. (Source: Value in Health)
Source: Value in Health - January 18, 2024 Category: International Medicine & Public Health Authors: Thomas Michaeli, Daniel Tobias Michaeli Tags: Health Policy Analysis Source Type: research
